Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
United States Natural Gas
UNG
Invesco Solar ETF
TAN
4
The Technology Select Sector SPDR® Fund
XLK
5
The Health Care Select Sector SPDR® Fund
XLV
US Stock MarketDetailed Quotes
Palisade Bio (PALI)
- 1.740
- -0.190-9.84%
Close Jun 5 16:00 ET
- 1.740
- 0.0000.00%
Post 20:01 ET
302.03MMarket Cap14.50P/E (TTM)
1.940High1.660Low4.32MVolume1.930Open1.930Prev Close7.58MTurnover3.23%Turnover RatioLossP/E (Static)173.58MShares2.85552wk High2.37P/B232.38MFloat Cap0.53052wk Low--Dividend TTM133.55MShs Float594000.000Historical High--Div Yield TTM14.51%Range %0.530Historical Low1.756Avg Price1Lot Size
PALI Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
PALI Orderflow
Unit: --
PALI Orderflow Trend
IntradayDayWeekMonth
No Data
Palisade Bio (PALI) News
B. Riley Securities Maintains Palisade Bio(PALI.US) With Buy Rating, Maintains Target Price $7
Verra Mobility, Zscaler, Box And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
H.C. Wainwright Maintains Palisade Bio(PALI.US) With Buy Rating, Maintains Target Price $7
Palisade Bio Files $300M Mixed Securities Shelf
Express News | Palisade Bio Inc - May Offer and Sell up to $300 Mln of Securities - SEC Filing
Express News | Palisade Bio Q1 EPS $(0.05) Misses $(0.04) Estimate
Palisade Bio (PALI) Stock Forum
$Palisade Bio (PALI.US)$
Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis
by Globe Newswire
Follow
Data demonstrate colon tissue PDE4/cAMP pathway modulation and sustained active metabolite exposure above IC90 across the dosing interval
Steady-state pharmacokinetic findings provide mechanistic support for previously reported Phase 1b clinical activity
Additional findings ...
Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis
by Globe Newswire
Follow
Data demonstrate colon tissue PDE4/cAMP pathway modulation and sustained active metabolite exposure above IC90 across the dosing interval
Steady-state pharmacokinetic findings provide mechanistic support for previously reported Phase 1b clinical activity
Additional findings ...
3
$Palisade Bio (PALI.US)$ What's going on with this? Down big yesterday. Buy the dip here?
$Palisade Bio (PALI.US)$ looks strange? why so much selling pressure after positive results?
1
$Palisade Bio (PALI.US)$ this stock screwed me up big time, bleeding because of positive results driving me crazy.
$Palisade Bio (PALI.US)$ why it keeps bleeding????
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)